1.
Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus. Can Diabetes Endocrinol Today. 2024;2(3):33–37. doi:10.58931/cdet.2024.2333